NCT04476563View on ClinicalTrials.gov

Checkpoint Inhibitor-induced Liver Injury

RecruitingOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

October 13, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Immune-Mediated Hepatitis
Interventions
DIAGNOSTIC_TEST

Obtaining biological samples

Biological samples (blood, urine, stool). Liver tissue will be obtained from ChILI group when clinically indicated

Trial Locations (1)

NG72RD

RECRUITING

University of Nottingham, Nottingham

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University of Nottingham

OTHER

NCT04476563 - Checkpoint Inhibitor-induced Liver Injury | Biotech Hunter | Biotech Hunter